APA (7th ed.) Citation

Untch, M., Jackisch, C., Schneeweiss, A., Conrad, B., Aktaş, B., Denkert, C., . . . Minckwitz, G. v. (2016). Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): A randomised, phase 3 trial. The lancet. Oncology, 17(3), . https://doi.org/10.1016/S1470-2045(15)00542-2

Chicago Style (17th ed.) Citation

Untch, Michael, et al. "Nab-paclitaxel Versus Solvent-based Paclitaxel in Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto-GBG 69): A Randomised, Phase 3 Trial." The Lancet. Oncology 17, no. 3 (2016). https://doi.org/10.1016/S1470-2045(15)00542-2.

MLA (9th ed.) Citation

Untch, Michael, et al. "Nab-paclitaxel Versus Solvent-based Paclitaxel in Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto-GBG 69): A Randomised, Phase 3 Trial." The Lancet. Oncology, vol. 17, no. 3, 2016, https://doi.org/10.1016/S1470-2045(15)00542-2.